TWC
VIR icon

TD Waterhouse Canada’s Vir Biotechnology VIR Stock Holding History

TD Waterhouse Canada’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$269 Buy
+30
New +$239 ﹤0.01% 2177
2023
Q3 		– Sell
-100
Closed -$3.25K – 1803
2023
Q2 		$3.25K Hold
100
– – ﹤0.01% 1464
2023
Q1 		$3.13K Hold
100
– – ﹤0.01% 1454
2022
Q4 		$3.41K Hold
100
– – ﹤0.01% 1419
2022
Q3 		$2.72K Hold
100
– – ﹤0.01% 1460
2022
Q2 		$3.34K Buy
+100
New +$2.33K ﹤0.01% 1463

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

TD Waterhouse Canada's VIR Position: Q1 2026 in Review

TD Waterhouse Canada opened a new position in Vir Biotechnology (VIR) in Q1 2026: 30 shares worth $269. The stake represents ﹤0.01% of the portfolio and ranks #2177 among its holdings. This is a return to the name: TD Waterhouse Canada previously reported a position in VIR as recently as Q2 2023.

TD Waterhouse Canada first reported a position in VIR in Q2 2022 and has held it in 6 quarters since. The position peaked at $3.41K in Q4 2022. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • TD Waterhouse Canada held 30 shares of Vir Biotechnology worth $269 as of Q1 2026.
  • Vir Biotechnology was a new TD Waterhouse Canada position in Q1 2026.
  • Vir Biotechnology made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #2177 holding.
  • TD Waterhouse Canada first reported a position in Vir Biotechnology in Q2 2022 and has held it in 6 quarters since.
  • TD Waterhouse Canada's Vir Biotechnology position peaked at $3.41K in Q4 2022.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.